Bill Gates, co-chair of the Bill and Melinda Gates Foundation, says progress is ongoing in the clinical trial of the M72 tuberculosis vaccine, expressing optimism in its offering 70 per cent efficacy.
Mr Gates said this while responding to a News Agency of Nigeria (NAN) question during an interview session with selected journalists on Tuesday in Abuja.
The interview was held on the sidelines of the 2024 NutriVision, a pan-African dialogue to discuss transformative solutions to combating malnutrition and shaping Africa’s future.
